Table 1 Characteristics of patients with HCC and their tumours
Number/median (range) | Percentage | |
---|---|---|
Age (years) | 55 (32–78) | |
Gender | ||
Male | 55 | (89%) |
HBV | 58 | (94%) |
HCV | 5 | (8%) |
Nontumour liver tissue | ||
Normal | 6 | (10%) |
Fibrosis | 19 | (31%) |
Cirrhosis | 37 | (60%) |
AJCC tumour stage | ||
1 | 2 | (3%) |
2 | 39 | (63%) |
3 | 15 | (24%) |
4 | 6 | (10%) |
Tumour maximum size (cm) | 3.5 (1.6–11.9) | |
Capsular invasion | ||
Y | 34 | (50%) |
N | 18 | (29%) |
No capsule | 10 | (21%) |
Microvascular invasion | ||
Y | 8 | (13%) |
N | 54 | (87%) |
Serum alpha fetoprotein (U/l) | 96 (2–699 800) |